Fingya (Fingolimod) can affect patients with kidney impairment. In adult patients with severe renal impairment, the blood levels of certain Fingya metabolites are increased, with no change in the apparent elimination half-life. Therefore, it is important for patients with renal impairment to discuss the use of Fingya with their healthcare provider, and regular monitoring may be necessary to ensure the safe use of the medication.
